PMCB stock touches 52-week low at $1.03 amid market challenges - Investing.com
2 weeks ago • Google News
PharmaCyte Biotech Inc (PMCB)
US$ 1.8009-0.5%
Price Chart
Key Statistics
Market Cap
$ 8.37M
P/E Ratio
0.91
Revenue (TTM)
$ 0
Volume
24.94K
52W High
$ 2.42
52W Low
$ 1.03
Dividend Yield
0.00%
Beta
-0.53
Technicals
50-Day MA
1.4833
200-Day MA
1.6817
52 Week High
2.4229
52 Week Low
1.03
About PMCB
PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States.
Employees
2
Headquarters
Las Vegas, NV
CEO
Mr. Joshua N. Silverman
Latest News
PharmaCyte Biotech Inc. (PMCB) reports earnings - qz.com
2025-03-17 • Google News
PharmaCyte Biotech Inc. (PMCB) reports earnings - qz.com
2024-12-13 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg